EPAS1 and cancer: Using a publically available data set of human sarcoma cell lines treated with various cancer therapeutics, we identified a significant correlation between EPAS1 mRNA abundance and sensitivity to the HDACi Vorinostat, also known as SAHA (Fig. 4b, Supplementary Fig. 5b)45.